Sanofi (SNY) Tops Q1 EPS by EUR0.20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Sanofi at forefront of fight against COVID-19 in Q1 2020
April 24, 2020 1:30 AM EDTSanofi at forefront of fight against COVID-19 in Q1 2020
Rapid and decisive response to COVID-19 global health crisis Sanofi showed resilience and maintained full business continuity worldwide including its global industrial network. Separate collaborations announced with BARDA, Translate Bio and GSK to develop novel COVID-19 vaccines.Global clinical program underway to evaluate Kevzara® in patients hospitalized with severe... More